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Abstract
Background: Production of pharmaceuticals in plants provides an alternative for chemical synthesis, fermentation or natural
sources. Nicotiana benthamiana is deployed at commercial scale for production of therapeutic proteins. Here the potential
of this plant is explored for rapid production of precursors of artemisinin, a sesquiterpenoid compound that is used for
malaria treatment.
Methodology/Principal Findings: Biosynthetic genes leading to artemisinic acid, a precursor of artemisinin, were combined
and expressed in N. benthamiana by agro-infiltration. The first committed precursor of artemisinin, amorpha-4,11-diene, was
produced upon infiltration of a construct containing amorpha-4,11-diene synthase, accompanied by 3-hydroxy-3-
methylglutaryl-CoA reductase and farnesyl diphosphate synthase. Amorpha-4,11-diene was detected both in extracts and in
the headspace of the N. benthamiana leaves. When the amorphadiene oxidase CYP71AV1 was co-infiltrated with the
amorphadiene-synthesizing construct, the amorpha-4,11-diene levels strongly decreased, suggesting it was oxidized.
Surprisingly, no anticipated oxidation products, such as artemisinic acid, were detected upon GC-MS analysis. However,
analysis of leaf extracts with a non-targeted metabolomics approach, using LC-QTOF-MS, revealed the presence of another
compound, which was identified as artemisinic acid-12-b-diglucoside. This compound accumulated to 39.5 mg.kg21 fwt.
Apparently the product of the heterologous pathway that was introduced, artemisinic acid, is further metabolized efficiently
by glycosyl transferases that are endogenous to N. benthamiana.
Conclusion/Significance: This work shows that agroinfiltration of N. bentamiana can be used as a model to study the
production of sesquiterpenoid pharmaceutical compounds. The interaction between the ectopically introduced pathway
and the endogenous metabolism of the plant is discussed.
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Introduction
Malaria is the most deadly parasitic disease in the world. It is
responsible for over 300 to 500 million cases and more than a
million deaths each year, especially amongst children and
pregnant women in Africa. During the 1960s, quinine-derived
medicines such as chloroquinine were used in a campaign to
eradicate malaria world wide. After initial success, gradually these
medicines lost their efficacy, due to the development of drug
resistance in the malaria parasite [1]. Consequently, new drug
application strategies to treat malaria were required and the World
Health Organization (WHO) in 2005 recommended the change to
artemisinin-based combined therapy (ACT) as first-line malaria
treatment [2].
Artemisinin has been discovered in the 1970s in China, as a
highly effective against multidrug-resistant Plasmodium spp., the
parasite that causes malaria [3]. It is a sesquiterpene lactone
endoperoxide, which is extracted from Artemisia annua L, an
herbaceous plant which is grown in China, Vietnam and eastern
Africa. Artemisinin is produced in glandular trichomes, and its
biosynthetic pathway has been elucidated ([4]; Fig. 1). The first
committed step in the artemisinin pathway is mediated by
amorphadiene synthase (ADS) [5] which converts farnesyl
diphosphate (FPP) into amorpha-4,11-diene. Subsequently, a
P450 enzyme (CYP71AV1) converts the amorpha-4,11-diene into
artemisinic alcohol, artemisinic aldehyde and artemisinic acid
[6,7]. For production of dihydro-artemisinic acid, the most likely
closest in planta-intermediate in artemisinin biosynthesis, a
reductase (Dbr2) is needed [8], as well as a aldehyde dehydroge-
nase (Aldh1) [9].
Availability of artemisinin is limited by the low yield of A. annua
and this is hindering availability of affordable malaria medicine to
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patients in developing countries. One approach to overcome this is
the improvement of A. annua as a production system. A genetic
map of A. annua has been published and genetic loci for artemisinin
content have been identified [10]. Alternative strategies involve the
production of artemisinin precursors in heterologous systems, such
as micro-organisms. While total chemical synthesis of artemisinin
is difficult and costly, the semi-synthesis of artemisinin from one of
its precursors could be a cost-effective and reliable source of
artemisinin. In search of alternative production systems, the
engineering of Saccharomyces cerevisiae to produce artemisinic acid
has been reported [6]. A large number of modifications, including
ectopic expression of the mevalonate pathway and the A. annua
genes for ADS and CYP71AV1 resulted in production of artemisinic
acid.
An agricultural crop with rapid accumulation of biomass at low
costs could be an alternative for both A. annua and microbial-based
production systems. Nicotiana spp have served as a host for the
heterologous production of many medically relevant proteins using
nuclear, chloroplast and transient transformation approaches
(reviewed by [11]) and also for the production of amorphadiene.
Introduction of amorphadiene synthase into Nicotiana tabacum
(tobacco) resulted in the production of minute amounts of
amorphadiene [5]. During the last five years, a number of
potential technical improvements have become available. For
example, the mitochondria of Arabidopsis thaliana have been shown
to be a better environment for sesquiterpene synthase expression
compared to the cytoplasma, probably due to a higher availability
of farnesyl diphosphate in that compartment [12]. Likewise, others
[13] have achieved significant improvement of sesquiterpene
production by targeting the sesquiterpene synthases to the
chloroplasts and co-expressing chloroplast-targeted farnesyl di-
phosphate synthase (FPS) and 3-hydroxy-3-methylglutaryl-CoA
reductase (HMGR). The addition of the latter two genes increases
the flux of sesquiterpene precursors to the sesquiterpene synthase:
FPS supplies the direct precursor of amorphadiene, farnesyl
diphosphate, while HMGR is considered the most important rate-
limiting step in the mevalonate pathway [14,15,16]. This
approach led to production levels of amorphadiene of up to
25 mg.kg21 tobacco [13].
For the production of artemisinin precursors beyond amorpha-
diene, the introduction of even more than these three genes is
required. When each gene is driven by the same promoter, often
the repeated sequences may lead to silencing of the promoter or
instability by recombination [17]. [13] avoided this by providing
each gene with a different promoter. With increasing numbers of
genes and hence promoters, however, the uncertainty that all these
promoters are active in exactly the same cells increases. Another
approach was described where two heterologous genes from the
carotenoid biosynthesis pathway can be co-expressed in tobacco
from a single promoter [18]. This is achieved by translating the
enzymes from a single open reading frame, in which the individual
proteins are separated by a viral peptide signal (2A). During
translation, the 2A peptide leads to ribosomal skipping, and
production of individual proteins. Recently it was described that,
by using the ribosomal skipping technology, up to four genes from
the glucosinolate pathway could be expressed from a single
promoter in tobacco [19].
In the present study, we set out to produce artemisinic acid in
Nicotiana benthamiana. To achieve this, multi-gene constructs with
ribosomal skipping sequences and mitochondrial targeting se-
quences are used, and combinations of amorphadiene synthase,
FPS, HMGR and CYP71AV1 are expressed. The results of this
approach are evaluated by GC-MS, as well as by untargeted
metabolomics using LC-QTOF-MS and NMR.
Figure 1. Biosynthetic pathway towards artemisinin. Genes relevant for this study have been indicated. ADS: amorpha-4,11-diene synthase;
Aldh1: aldehyde dehydrogenase 1; CYP71AV1: amorpha-4,11-diene monooxygenase; DBR2: Artemisinic aldehyde double-bond reductase; FPS:
farnesyl diphosphate synthase; HMGR: 3-hydroxy-3-methylglutaryl-CoA reductase; FPP: farnesyl diphosphate; AAOH: artemisinic alcohol; AAA:
artemisinic aldehyde; AA: artemisinic acid; DHAAA: dihydro-artemisinic aldehyde; DHAA: dihydro-artemisinic acid.
doi:10.1371/journal.pone.0014222.g001
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Results
Amorphadiene synthase fused to FPS and HMGR
improves amorphadiene biosynthesis in infiltrated leaves
To be able to express ADS in combination with FPS and HMGR,
a construct was made in which these genes were in a single open
reading frame, separated by 2A ribosomal skipping sequences
(35S-mAmFH-2A) (Fig. 2). The effectiveness of this construct was
compared with a single amorphadiene synthase (35S-mA).
Infiltrated N. benthamiana leaves were analyzed for emission of
amorphadiene into their headspace. In the headspace of the 35S-
mA and the 35S-mAmFH-2A plants, amorphadiene was detected
while this was not observed for pBinPlus-infiltrated leaves. In the
35S-mA-infiltrated leaves, amorphadiene production was
0.47 mg.kg21.24 h21 whereas in the 35S-mAmFH-2A leaves
production was 0.70 mg.kg21.24 h21 (Table 1). Even though
amorphadiene production upon infiltration with the 35S-
mAmFH-2A constructs was on average two-fold higher than with
35S-mA, due to the high variability in emission between individual
leaves, the difference in the headspace was not significant
(P.0.05).
In ethyl acetate extracts of the leaves, amorphadiene was also
detected (Fig. 3). In addition to amorphadiene, a second, more
dominant novel peak was detected at 16.8 min, in both 35S-mA
and 35S-mAmFH-2A – infiltrated leaves, but not in control-
infiltrated leaves. The identity of this compound remains to be
established. Upon infiltration with the single gene 35S-mA
construct 0.9 mg.kg21 fwt amorphadiene and an estimated
5.6 mg.kg21 fwt of the unknown compound were produced.
Upon infiltration with the 35S-mAmFH-2A construct
6.2 mg.kg21 fwt of amorphadiene and 20.8 mg.kg21 fwt of the
unknown compound were produced. Both amorphadiene and the
unknown compound were significantly increased in the 35S-
mAmFH-2A leaf extracts compared with leaves infiltrated with
ADS alone (P,0.01).
Having established that the multi-gene 35S-mAmFH-2A
construct resulted in the production of significantly more
amorphadiene than the single-gene 35S-mA construct, we
investigated what the contribution of mFPS and tHMGR was.
Hereto, individual constructs RBC-mA, RBC-mFPS or RBC-
tHMGR were used for co-infiltration experiments. In these
experiments, gene expression was driven by the RBC promoter,
instead of the 35S promoter and no P19 was co-infiltrated.
Therefore, the results with these constructs can not be compared
with the previous experiments using 35S-mAmFH-2A, but they
can be used to assess the individual contribution of FPS and
HMGR to the flux increase to amorphadiene. Infiltration of RBC-
mA alone resulted in the production of 0.011 mg.kg21 fwt of
amorphadiene and 0.006 mg.kg21 fwt of the unknown compound.
Co-infiltration of RBC-mA with RBC-mFPS resulted in a
relatively modest increase in the production of amorphadiene
and the unknown compound to 0.04 mg.kg21 fwt and
0.06 mg.kg21 fwt, respectively. However, co-infiltration of RBC-
mA with RBC-tHMGR resulted in a strong (300 to 400-fold)
increase in accumulation of amorphadiene and the unknown
compound (Table 1). Adding RBC-mFPS to the combination of
RBC-mA and RBC-tHMGR did again not result in an increase in
production. Apparently co-expression of in particular tHMGR has
a strong contribution to amorphadiene biosynthesis in the
mitochondria. The expression of FPS in the mitochondria,
however, seems to be less rate-limiting.
Amorphadiene is available for oxygenation by CYP71AV1
To further construct the pathway towards artemisinin in N.
benthamiana, 35S-mAmFH-2A was co-infiltrated with a construct
containing A. annua CYP71AV1. Co-expression of 35S-mAmFH-2A
with 35S-CYP71AV1 caused a strong decrease in amorphadiene
in the headspace compared with the 35S-mAmFH-2A construct
alone (23-fold, from 0.70 to 0.03 mg.kg21 fwt.24h21; Table 1).
Also in the ethylacetate extracts, both the amorphadiene and the
unknown compound decreased strongly (31-fold from 6.2 to
0.2 mg.kg21 fwt and 12-fold from 20.8 to 1.7 mg.kg21 fwt,
respectively; Table 1). Hence we assumed that amorphadiene was
converted by CYP71AV1, for example to artemisinic alcohol
(AAOH), artemisinic aldehyde (AAA) or artemisinic acid (AA)
(Fig. 1). However, these metabolites were not observed in the GC-
Figure 2. Constructs used for the different infiltration experiments. 35S: 35S CaMV promoter; cox: mitochondrial targeting signal; ADS:
amorphadiene synthase; Term: Rubisco terminator; CYP71AV1: amorphadiene oxidase; FPS: farnesyl diphosphate synthase; tHMGR: truncated 3-
hydroxy-3-methylglutaryl-CoA reductase. RBC: rubisco promoter.
doi:10.1371/journal.pone.0014222.g002
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MS analysis, nor were any other novel metabolites detected, in
either the headspace or the extract by GC-MS analysis.
To investigate whether any other metabolic changes were
caused by co-infiltration of CYP71AV1, an untargeted LC-QTOF-
MS analysis of methanol extracts from leaves was carried out.
Mass profiles of the pBinPlus, 35S-CYP71AV1, 35S-mAmFH-2A
and 35S-mAmFH-2A +35S-CYP71AV1 samples were recorded
and compared. The comparison of the 35S-mAmFH-2A +35S-
CYP71AV1 co-infiltrated leaves to the mAmFH-2A infiltrated
leaves revealed that, of the 6645 mass peaks taken into
consideration, 63 mass peaks were increased .2-fold (P,0.01)
due to co-infiltration of 35S-CYP71AV1 (Table S1). Fourty-eight
of these mass peaks eluted at the same retention time of 28.0 min.
Inspection of the mass chromatograms learned that indeed at 28.0
minutes, a clear peak was present in the 35S-mAmFH-2A +35S-
CYP71AV1 extracts, which was absent in the control samples
(Fig. 4). Further analysis of this peak by LC-MS showed dominant
masses at m/z 1115.5190 ([2M-H2O-H]2) and at m/z 557.2548
([M-H]2) (Fig. S1). LC-MS/MS of the base peak mass at m/z 557
showed fragments at m/z 395.2071 [M-Glc-H]-) and m/z
Table 1. Production of different artemisinin precursors in N. benthamiana infiltrated with a range of different constructs.
Headspace Ethylacetate extract Ethylacetate extract Methanol extract
amorphadiene
(mg.kg21 fwt.24 h21)
amorphadiene
(mg.kg21 fwt)
unknown compound
(mg.kg21 fwt)1
artemisinic acid-12- b-diglucoside
(mg.kg21 fwt)
pBin3 0 0 0 0
35S-mA 0.4760.22 0.960.2 5.662.6 0
35S-mAmFH-2A 0.7060.34 6.260.6 20.861.6 0
35S-mAmFH-2A +
35S-CYP71AV1
0.0360.01 0.260.01 1.760.4 39.569.4
RBC-mA + pBin nd2 0.01160.009 0.00660.004 nd
RBC-mA + RBC-mFPS nd 0.0460.009 0.0660.01 nd
RBC-mA + RBC-tHMGR nd 3.261.2 2.660.5 nd
RBC-mA + RBC-mFPS + RBC-tHMGR nd 0.960.3 1.560.6 nd
1concentration based on the response factor of amorphadiene.
2nd = not determined;
3Constructs are described in the text.
doi:10.1371/journal.pone.0014222.t001
Figure 3. GC-MS chromatograms (total ion count) of ethyl acetate extracts of leaves infiltrated with 35S-mAmFH-2A (top) and a
control construct (bottom).
doi:10.1371/journal.pone.0014222.g003
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233.1562 ([M-2Glc-H]-) (Fig. S2). The presence of the 233.1562
mass peak suggested that artemisinic acid (calculated m/
z=233.1547) is part of this molecule, while the loss of 2 units of
mass 162 suggests the presence of a di-C6-glycoside group. These
observations lead us to hypothesize that the peak at 28.0 min in
the LC-MS chromatograms represents an artemisinic acid-
dihexoside.
Identification of artemisinic acid-12-b-diglucoside
The putative artemisinic acid-dihexoside was purified by LC-
SPE and subjected to 1H and 13C NMR. Comparison to an
original standard of artemisinic acid was used to assign resonances
to artemisinic acid (Table 2). A perfect overlap of resonances with
artemisinic acid was observed, except that the the acetylene group
of the artemisinic acid-moiety at C13 was slightly shifted
compared to the artemisinic acid reference compound. Moreover
the proton resonance of the OH of the carboxylic acid moiety at
position 16 (the oxygen at carbon 12; Fig. 5) of the molecule, had
disappeared. This supports coupling of the glycoside-moiety via
the artemisinic acid acid function.
The purified artemisinic acid-dihexoside compound was treated
with different glycosidase enzymes and analyzed on LC-MS.
Treatment with b-glucosidase showed a strong decrease in the m/z
557.3 peak at Rt = 28.0 min (representing artemisinic acid-
diglucoside), appearance of a novel peak of m/z=791.5 at
Rt = 53.1 min (representing artemisinic acid-monoglucoside
[2M–H]) (Fig. S3), and trace amounts of artemisinic acid in GC-
MS analysis. No decrease in the m/z 557 peak, or appearance of
the m/z 791 peak, could be observed after treatment with a-
glucosidase or b-galactosidase, which lead us to conclude that the
novel product is artemisinic acid-12-b-diglucoside.
Quantification of artemisinic acid-12-b-diglucoside
To quantify the artemisinic acid-diglucoside produced, leaf
extracts were first deglycosylated with a glucosidase mixture,
Viscozym L. The deglycosylated artemisinic acid was then
quantified by GC-MS. Consistent with the glycosidic nature of
the artemisinic acid-diglucoside, Viscozym treatment resulted in
the production of artemisinic acid (Fig. S4). The amount of
artemisinic acid released by the treatment was 16.6 mg.kg21 fwt,
which corresponds to 39.5 mg.kg21 fwt artemisinic acid-12-b-
diglucoside (Table 1).
Discussion
In this paper, production of a non-protein pharmaceutical in N.
benthamiana is described. N. benthamiana can produce several
precursors of the sesquiterpenoid antimalarial drug artemisinin.
Amorphadiene production was strongly elevated relative to
experiments reported earlier by us [5]. Two novel strategies were
used: firstly, amorphadiene synthase was targeted to the
mitochondria, and secondly, mitochondrial FPS and cytosolic
HMGR were co-expressed using a ribosomal skipping construct.
When this gene combination was co-infiltrated with amorphadiene
oxidase a novel compound identified as artemisinic acid-12-b-
diglucoside was produced at 39.5 mg.kg21 fwt. Thereby, this
research adds to the potential of N. benthamiana as a model for
production of plant-made pharmaceuticals. So far, N. benthamiana
has been successfully explored as a model for expression of
therapeutic proteins, such as antibodies [20]. To achieve this, a
number of quick and efficient methods have been developed for N.
benthamiana, including agro-infiltration and viral vectors. More
recently, N. benthamiana agro-infiltration experiments have also
been used to reconstruct the glucosinolate biosynthesis pathway
Figure 4. LC MS chromatograms (total ion count) of methanol extracts of N. benthamiana leaves, infiltrated with 35S-mAmFH-2A
and 35S-CYP71AVI (top) and 35S-mAmFH-2Aand pBinPlus (bottom). Y-axis scale is identical in both chromatograms.
doi:10.1371/journal.pone.0014222.g004
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[21]. In the present paper, agro-infiltration of N. benthamiana is
deployed to rapidly screen engineering concepts for sesquiterpene
production, and to investigate the interaction of the sesquiterpene
product with endogenous metabolism of the host.
Emission, accumulation and modification of
amorphadiene
Production of sesquiterpenes in transgenic plants has so far
mostly been investigated by extraction of leaf material with
organic solvents [5,13]. For research on plant-insect interaction,
the emission of ectopic sesquiterpenes into the headspace has been
described [12,22]. Our headspace trapping experiments on N.
benthamiana leaves show that part of the amorphadiene that is
produced is emitted. After 10 days the concentration of
amorphadiene in leaves infiltrated with the 35S-mA construct
(0.9 mg.kg21 fwt amorphadiene) is in the same order of magnitude
as the emitted amorpha-4,11-diene (0.47 mg.kg21 fwt.24 h21).
When multiple days of emission are taken into account, the
emitted amount is probably significantly higher than the
accumulated amount.
In the present paper, the sesquiterpene synthase was targeted to
the mitochondria, using the COX targeting sequence, instead of
the cytosol, where sesquiterpene biosynthesis takes place in planta.
A farnesyl diphosphate synthase with mitochondrial targeting has
been identified in Arabidopsis [23] and it has been shown that
fusion of nerolidol synthase from strawberry to the COX targeting
sequence supports biosynthesis of nerolidol (emitted into the
headspace of transgenic Arabidopsis plants) whereas this was not
achieved using cytosolic nerolidol synthase [12]. This is in keeping
with our observation that amorphadiene is readily observed in
extracts from N. benthamiana infiltrated with 35S-mA (0.9 mg.kg21),
while cytosolic production of amorphadiene in stable N. tabacum
tranformants occurred at much lower levels (0.2 to 1.7 mg.kg21;
[5]).
Production of amorphadiene was boosted by fusing ADS,
through ribosomal skipping sequences, to FPS and tHMGR.
Although emitted amorphadiene hardly increased (from 0.47 to
0.70 mg.kg21 fwt.24 h21) the concentration of amorphadiene
accumulated in the leaf strongly increased (from 0.9 to
6.2 mg.kg21 fwt). Apparently, the emission of amorphadiene
becomes limiting when biosynthesis increases resulting in
increased accumulation in the plant. It is unclear whether N.
benthamiana stores the heterologous sesquiterpenes in specific
organs, such as glandular trichomes (and from which evaporation
then also occurs), and whether the 35S-promoter mediates
expression in these organs. Alternatively, amorphadiene could be
directly emitted from the mesophyl cells ([24] and refs therein).
Very little is known about the mechanisms involved in volatile
emission from Nicotiana leaves, and this aspect should be further
investigated, for example using dynamic headspace trapping
methods.
The strong increase in the production of amorphadiene by the
use of a translational fusion of ADS to FPS and tHMGR could have
several reasons. Overexpression of tHMGR has been shown to
Table 2. 1H-NMR and 13C-NMR parameters of artemisinic acid
and artemisinic acid-12-b-diglucoside.
artemisinic acid artemisinic acid-12-b-diglucoside
C13
(ppm)
H1
(ppm)
Atom
numberb
C13
(ppm)
H1
(ppm)
Atom
number
28,4 1,39 1 28,8 1,40 1
38,9 2,51 2 38,4 2,48 2
43,2 2,64 3 42,8 2,7 3
26,7 1.39/1.32 4 27,3 1.39/1.32 4
36 1.70/1.06 5 35,8 1.71/1.08 5
42,5 1,37 6 42,1 1,40 6
26,9 1.90/1.77 7 26,9 1.94/1.77 7
26,4 1.94/1.52 8 25,8 1,52 8
135,8 9
120,9 4,98 10 120,8 4,97 10
144,1 11
168,6 12
124,9 6.24/5.47 13 126,9 6.50/5.60 13
19,9 0,89 14 20 0,90 14
23,7 1,57 15 23,9 1,58 15
9.10 16a
105 4,53 glucose-1
93,7 5,63 glucose-1
82,2 3,58 glucose
77,9 3,38 glucose
77,5 3,29 glucose
77 3,18 glucose
76,9 3,6 glucose
75,4 3,1 glucose
71,2 3,25 glucose
70,4 3,37 glucose
62 3,58 glucose-6
61,8 3,72 glucose-6
aproton bound to oxygen in the carboxylic moiety of artemisinic acid.
bAtom numbers refer to Fig. 5.
doi:10.1371/journal.pone.0014222.t002
Figure 5. Structure of artemisinic acid (R = H) and artemisinic
acid-12-b-diglucoside (R = b-glucose-b-glucose). Atom numbers
are referred to in Table 2.
doi:10.1371/journal.pone.0014222.g005
Artemisinin in Benthamiana
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e14222
boost sesquiterpene expression [13,15]. Likewise, co-expression of
FPS with sesquiterpene synthases in the chloroplast compartment
improved sesquiterpene expression [13]. In the present work ADS
and FPSwere co-expressed in the mitochondria. Co-infiltration with
single-gene constructs containing tHMGR and ADS shows that
tHMGR, which is expressed without targeting signal, strongly
enhances amorphadiene production, much more than co-expres-
sion of mitochondrial targeted FPS (Table 1). Apparently, HMGR-
produced isopentenyl diphosphate (IPP) is also available to the
mitochondria and not only to the plastids as was demonstrated [13].
Also, the transport capacity to the mitochondria for IPP is
apparently not limiting, or it may be up-regulated upon increased
substrate demand. A second advantage of the 2A-coupled ADS-FPS-
HMGR construct could be the coordinated expression of each of the
subunits. When individual integrations into the genome are used for
each of the subunits, genes that are part of the same pathway may
not be expressed to the same level or even in the same cell, even
when expressed from identical promoters. The latter is illustrated by
experiments showing that different integration events of 35S-
luciferase constructs lead to poorly overlapping expression patterns
[25]. Obviously, when HMGR, FPS and ADS would not be
expressed in the same cells, the effect of stimulating the flux into
the terpene production pathway would be lost. A potential
disadvantage of the 2A system could be that proteins downstream
in the triple-gene open reading frame may have a reduced
expression [19]. Therefore careful tuning of the order of genes
may be needed to achieve optimal sesquiterpene production.
Coexpression of a cytochrome P450 leads to
accumulation of artemisinic acid di-hexoside
The advantage of a plant host for the production of
sesquiterpenoids is their ability to accommodate P450 enzymes.
In prokaryotic organisms, the use of specific, plant-derived P450s
requires extensive engineering [6]. Therefore yeast, which also has
a membrane system, has often been used as a model system for
plant P450 expression (Olry et al., 2007; Urban et al., 1997).
However, full conversion of sesquiterpene substrates in yeast
requires extensive optimization of the genetics and growth
conditions [6]. The work of Lucker et al. [26] shows that the
plant P450 limonene-3-hydroxylase, when expressed in tobacco
together with limonene synthase, readily converts a significant
amount of the monoterpene limonene into (+)-trans-isopiperitenol.
Here we show that CYP71AV1, a sesquiterpene oxidizing P450,
also functions efficiently in N. benthamiana, and leads to almost
complete conversion of amorphadiene. Interestingly, the interme-
diates in the oxidation of amorphadiene to artemisinic acid,
artemisinic alcohol and artemisinic aldehyde, were not detectable
in our experiments. This possibly reflects an efficient catalytic
environment for CYP71AV1 when expressed in N. benthamiana.
N. benthamiana stores artemisinic acid principally as artemisinic
acid-diglucoside. Apparently, glycosyl transferases of N. benthamiana
– constitutively active or induced upon introduction of these
transgenic metabolites - are very efficient in catalyzing this
conversion, since hardly any other metabolite of amorphadiene
could be observed. N. tabacum is known to express, upon pathogen
infection, a UDP-glucosyl transferase TOGT1 that glycosylates the
acid moiety of phenolic compounds such as salicylic acid and
coumaric acid [27]. The homologue of this enzyme in N.
benthamiana may be the enzyme that initiates the modification of
artemisinic acid to the diglucoside. The diglucoside is likely stored
into the vacuole by a glucoside specific H+-coupled transporter,
like has been shown for other phenolic glucosides [28]. Storage of
target metabolites as glycoside may have the additional advantage
that the storage capacity of the vacuole is used and that high
concentrations can be achieved without phytotoxic effects. Glycosides
can be extracted relatively easily from plants by hydrophylic solvents,
and, after hydrolysis, the desired aglycon can be conveniently
recovered at high concentrations in an organic phase.
The interaction between endogenous metabolism and products
of ectopically expressed genes, as we observe here with the
production of artemisinic acid di-glucoside, is a highly significant
aspect of plant metabolic engineering. Often this aspect is ignored,
because the applied detection methods are focused on finding the
anticipated product. By use of a broad spectrum of unbiased
analytical methods such as LC-MS, GC-MS of both extracts and
headspace, and statistical data analysis tools, the role of metabolic
cross-talk between endogenous and ectopic pathways can be
uncovered. Metabolic cross-talk as a result of plant metabolic
engineering is a phenomenon that has been scarcely described.
Nevertheless, it may offer novel products with potential new
biological activities, as has been shown for yeast [29], and as we
show here for plants.
Opportunities to increase artemisinic acid-productivity of
N. benthamiana
The application of N. benthamiana agroinfiltration is a novel and
highly effective way for producing sesquiterpenoids. In 10 days,
infiltrated N. benthamiana leaves accumulated up to 6 mg.kg21 fwt
amorphadiene, depending on the construct used, in addition to an
emission of amorphadiene at 0.5 mg.kg21 fwt.24 h21, and
accumulation of an amorphadiene-related compound to an
estimated amount of 20 mg.kg21 fwt. This is a significant
improvement relative to the levels of amorphadiene (0.2 to
1.7 mg.kg21 fwt) that were obtained earlier using ADS alone in
transgenic N. tabacum [5]. Later, strong improvement was achieved
by the co-expression of ADS and FPS with chloroplast targeting in
combination with un-targeted tHMGR resulting in an amorpha-
diene production of 25 mg.kg21 fwt [13]. Using N. benthamiana
agroinfiltration we managed to produce concentrations that are in
the same order of magnitude as in the latter paper in only 10 days.
In the present paper, artemisinic acid was produced to
16.6 mg.kg21 fwt (as 39.5 mg.kg21 fwt artemisinic acid digluco-
side) in N. benthamiana by agroinfiltration. This compound has not
yet been produced in stable transgenic tobacco.
The conversion of amorphadiene towards artemisinic acid
diglucoside is quite efficient. The amount of amorphadiene found
in the extracts of plants infiltrated with 35S-mAmFH-2A
(6.2 mg.kg21) is lower than is found as artemisinic acid-12-b-
diglucoside in the presence of CYP71AVI (16.6 mg.kg21 artemi-
sinic acid; Table 1). The excess of oxygenated amorphadiene
could derive from emitted amorphadiene, and/or from the
amorphadiene-related unknown compound, for which the identity
could not be established. Both of these potential sources are
dramatically reduced upon co-infiltration (Table 1), suggesting
that also (precursors of) the unknown compound is turned over by
CYP71AVI. The potential capacity of amorphadiene (including
the unknown compound) was estimated at 27.0 mg.kg21 (Table 1),
though it should be noted that the response-factor of the unknown
compound is not known. The loss of610 mg.kg21 amorphadiene-
related compounds could result from the fact that the co-
infiltration of CYP71AVI causes a reduction in ADS production,
due to dilution of the Agrobacterium expressing ADS. Alternatively, a
fraction of the amorphadiene may have been metabolized into
other compounds. However, other compounds, except for the
unknown compound, were hardly found in the LC-MS (Table S1)
or in the GC-MS analysis (not shown).
N. benthamiana leaves are difficult to compare to yeast cultures,
where artemisinic acid has been produced to a level of
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100 mg.L21 [6]. Though fermentation of microbes to produce
plant compounds has strongly developed over the last 5 years,
plants offer a number of benefits [30]. These include low startup
costs, high flexibility in terms of scale and storage, and the
potential to produce high product volumes at relatively low cost.
We feel that N. benthamiana deserves further study to develop it as a
production host. The agro-infiltration system used in this study is
suitable for functional testing of genes and constructs, but
relatively inefficient for large-scale metabolite production. Analysis
by SDS PAGE of leaves subjected to agro-infiltration with mADS
did not reveal detectable ADS protein (data not shown). However,
[31] report accumulation of recombinant proteins to up to 10% of
soluble protein in N. benthamiana, in 10 days, using a plant virus-
based modular expression vector. Such vector optimization steps,
in addition to careful balancing of HMGR, ADS and CYP71AV1
expression, may still need to be made in N. benthamiana, before
competitive production of artemisinic acid-derivatives can be
achieved. For practical application, stable transformation of N.
benthamiana, or likely other plant species, is probably required to
reach commercially attractive high yields comparable to Artemisia
annua or engineered micro-organisms.
Conclusions
This work shows that agroinfiltration of N. bentamiana can be
used as a model to study the production of sesquiterpenoid
pharmaceutical compounds. By using mitochondrial targeting and
2A technology, novel compounds, formed by metabolic crosstalk
between the endogenous metabolism and the ectopically expressed
sesquiterpene biosynthetic pathway, can be produced. By using an
untargeted metabolomics approach, and analysis of the headspace,
organic extracts and semipolar extracts, such novel metabolites
can be uncovered.
Material and Methods
Single constructs and 2A construct (mAmFH-2A)
An overview of the constructs used in this study is provided in
Fig. 2. PCRs were performed with Phusion enzyme (Finnzymes,
Finland). All the plasmids were constructed using standard cloning
methods (restriction and ligation). The final and intermediate
vectors were checked by restriction and sequencing. The 35S-mA
vector was created by amplifying the ADS cDNA using AdsF and
AdsR primers (Table 3) introducing a BamHI and a NotI
restriction site. The restricted PCR product was introduced in the
pIV2A_2.5 vector containing a CaMV35S promoter, CoxIV
mitochondrial targeting sequence and a RbcS1 terminator (www.
pri.wur.nl/UK/products/ImpactVector/).
CYP71AV1 was obtained by digestion using BamHI and KpnI
from a pYeDP60 vector provided by Anna-Margaretha Ryden.
ImpactVector C3.1 (www.pri.wur.nl/UK/products/ImpactVec-
tor/) was adapted by insertion of a KpnI restriction site. For this
purpose, an oligodimer was constructed as follows: two oligo’s
(GATCCATTTCGGTACCAATTAGC and GGCCGCTAAT-
TG GTACCGAAATG) were paired and kinase-treated. The
C3.1 vector containing a CaMV35S promoter and a RbcS1
terminator, was restricted with BamHI and NotI and the oligo-
dimer was ligated into the vector. The resulting C3.1 + KpnI
vector was digested with BamHI and KpnI. Gel-purified and
BamHI and KpnI digested CYP71AV1 gene was ligated into this
vector, to yield 35S-CYP71AVI.
Several steps were required to construct the 2A vector with the
genes: ADS, FPS and tHMGR (truncated 3-hydroxy-3-methylglu-
taryl-CoA reductase). tHMGR represents the truncated sequence of
HMGR from Arabidopsis thaliana (accession number: J04537,
2195bp), mADS and mFPS represent the mitochondrial target
sequence: Cox IV secretion signal from S. cerevisiae (GeneID:
852688) combined with the sequence of ADS from Artemisia annua
(accession number: AAF61439, 1641bp) and the same Cox IV
sequence fused to the FPS2 sequence from A. thaliana (Genebank:
NM_117823, 1026bp), respectively.
tHMGR was amplified using primers tHMGRF and tHMGRR
(Table 3), and, after cleavage with BamHI and NotI, was cloned in
vector pImpactVector3.1, which is a variant of pImpactVector1.1
but contains a CaMV35S promoter and a RbcS1 terminator
(http://www.pri.wur.nl/UK/products/ImpactVector/). The re-
sulting plasmid was cleaved using XbaI and BamHI restriction
Table 3. Oligonucleotides used in this study.
Name Sequence (59-.39)
AdsF GGCGGGATCCAATGTCACTTACAGAAGAAAAACCTATTCGCC
AdsR AGATCTGCGGCCGCTATATACTCATAGGATAAACGAG
tHMGRF GACGTAAGGGATGACGCACAATC
tHMGRR AGATCTGCGGCCGCCTATGTTGTTGTTGTTGTCGTTGTCGTTGC
XbaMluBamHF CTAGACGAGGAATCGCTACGCGTCAG
XbaMluBamHR GATCCTGACGCGTAGCGATTCCTCGT
MluStrepBamHF CGCGTTGGTCTCATCCACAGTTCGAGAAGATG
MluStrepBamHR GATCCATCTTCTCGAACTGTGGATGAGACCAA
MtXbaADSF GCTCTAGAATGTTGTCACTACGTCAATCT
ADSStrepNotR AGTTTAGCGGCCGCCTCTTCTCGAACTGTGGATGAGACCATCCACCGCCTATACTCATAGGATAAACGA
F2AMluF GGCCGCAGACTTTGAATTTTGACCTTCTCAAGTTGGCGGGAGACGTGGAGTCCAACCCAGGGCCCACTAGTGGTGGCATATACGCGTA
F2AmluR GATCTACGCGTATATGCCACCACTAGTGGGCCCTGGGTTGGACTCCACGTCTCCCGCCAACTTGAGAAGGTCAAAATTCAAAGTCTGC
MtXbaFDSF GCTCTAGAGCACTAGTATGTTGTCACTACGTCAATCT
FDSStrepNotR AGTTTAGCGGCCGCCCTTCTCGAACTGTGGATGAGACCACTTCTGCCTCTTGTAGATCT
T2AF GGCCGCGAGGgCAGAGGAAGTCTTCTAACATGCGGTGACGTCGAGGAGAATCCTGG CCCAACGCGTA
T2AR GATCTACGCGTTGGGCCAGGATTCTCCTCGACGTCACCGCATGTTAGAAGACTTCCTCTGCCCTCGC
doi:10.1371/journal.pone.0014222.t003
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enzymes, and a duplex of oligonucleotides XbaMluBamHF and
XbaMluBamHR was introduced. The resulting plasmid was
cleaved with MluI and BamHI, and a linker of duplex
MluStrepBamHF and MluStrepBamHR was introduced. The
mADS cDNA was amplified using MtXbaADSF and ADSStrep-
NotR, and cloned into pImpactVector1.1. In this plasmid, the
F2A peptide sequence was introduced as a linker of F2AMluF and
F2AMluR in the NotI and BglII sites. The FPS cDNA was
amplified using MtXbaFDSF and FDSStrepNotR, and cloned
into pImpactVector1.1. In this plasmid, the T2A peptide sequence
was introduced as a linker of T2AF and T2AR in the NotI and
BglII sites. The ADS unit was cleaved from the pImpactVector1.1
by XbaI and MluI and introduced in the HMGR unit cleaved with
the same restriction sites. Subsequently, the FPS unit was added to
this construct by using SpeI and MluI restriction sites. The final
construct was called 35S-mAmFH.
For individual expression, the ADS and FDS cDNAs were
cloned into pImpactVector1.5, to fuse them to the RBC promoter
and the CoxIV mitochondrial targeting sequence. The tHMGR
gene was cloned into pImpactVector1.1 using BamHI and NotI
restriction sites, to fuse it to the RBC promoter.
In order to construct a plant expression vector, the final
constructs in pImpactVector were restricted using AscI and PacI.
The fragments were ligated into the pBinPlus binary vector [32]
between the right and left border of the T-DNA.
Agrobacterium transformation
Agrobacterium tumefaciens AglI strain contains a disarmed Ti plasmid
that provides the vir gene functions. It harbors rifampicillin and
carbenicillin chromosomal resistance genes [33]. The binary
vector was introduced into AglI by electrotransformation.
Transient expression in leaves of Nicotiana benthamiana
Agrobacterium strains were grown at 28uC at 220 rpm for
24 hours in LB media with kanamycin (50 mg/L) and rifampicillin
(34 mg/L). Cells were harvested by centrifugation for 20 min at
4000 g and 20uC and then resuspended in 10 mM MES buffer
containing 10 mM MgCl2 and 100 mM acetosyringone (49-
hydroxy-39,59-dimethoxyacetophenone, Sigma) to a final OD600
of 0.5, followed by incubation at room temperature and 50 rpm
for 150 minutes. For co-infiltration, equal volumes of the
Agrobacterium strains were mixed. In all experiments, an Agrobacter-
ium strain harbouring a gene encoding the TBSV P19 protein was
added to maximize protein production by suppression of gene
silencing [34]. Nicotiana benthamiana plants were grown from seeds
on soil in a greenhouse with 16 h light at 28uC (16 h)/25uC (8 h).
Strain mixtures were infiltrated into leaves of four-week-old N.
benthamiana plants using a 1 mL syringe. The bacteria were slowly
injected into the abaxial side of the leaf. The plants were grown
under greenhouse conditions until further analysis.
Headspace analysis and GC-MS thermodesorption
Steel sorbent cartridges (89 mm 66.4 mm O.D.; Markes)
containing 200 mg Tenax TA 20/35 for collection of volatiles
were conditioned for 40 min at 280uC under a nitrogen flow of 20
psi using a TC-20 multi-tube conditioner and were kept airtight
with brass caps until use. Freshly collected N. benthamiana leaves
were placed on water enclosed in a glass container. Air was sucked
through the containers with a flow rate of 90 ml.min21 for 24 h
through the Tenax cartridges to trap plant-produced volatiles.
Incomming air was purified with a second Tenax cartridge. Before
GC-MS analysis, the cartridges were dried for 15 min at room
temperature with a nitrogen flow of 20 psi.
Headspace samples were analyzed with a Thermo TraceGC
Ultra connected to a Thermo TraceDSQ quadrupole mass
spectrometer (Thermo Fisher Scientific, Waltham). Before ther-
modesorption, traps were flushed with helium at 50 ml min21 for
2 min to remove moisture and oxygen. After flushing the collected
volatiles were desorbed from the Tenax traps at 220uC (Ultra;
Markes, Llantrisant) for 5 min with a helium flow of 50 ml.min21.
The released compounds were focused on an electrically cooled
sorbent trap (Unity; Markes, Llantrisant) at a temperature of 5uC.
Volatiles were injected on the analytical column (ZB-5MSI, 30 m
60.25 mm ID, 1.0 mm – film thickness, Zebron, Phenomenex) in
splitless mode by ballistic heating of the cold trap to 250uC for
3 min. The temperature program started at 40uC (3 min hold) and
rose 10uC.min21 to 280uC (2 min hold). The column effluent was
ionised by electron impact (EI) ionisation at 70 eV. Mass scanning
was done from 33 to 280 m/z with a scan time of 4.2 scans.s21.
The eluted compounds were identified using Xcalibur software
(Thermo, Waltham) by comparing the mass spectra with those of
authentic reference standards.
GC-MS analysis of extracts
Compounds accumulated in the leaves were analysed by
snapfreezing and grinding 500 mg infiltrated leaf from each
treatment in liquid nitrogen and extraction with 2 ml ethyl acetate.
The extracts were prepared by brief vortexing and sonication for
15 min. Then the extracts were centrifuged for 15 min at 3500 rpm
and dehydrated using anhydrous Na2SO4. For analysis of artemisinic
acid, samples were methylated using diazomethane. The samples
were analyzed by GC-MS using a gas chromatograph (5890 series II,
Hewlett-Packard) equipped with a 30 m60.25 mm, 0.25 mm film
thickness column (5MS, Hewlett-Packard) and a mass-selective
detector (model 5972A, Hewlett-Packard). For analysis, 1 ml was
injected, and the column temperature was increased from 45uC to
280uC in 20 minutes. Standards of amorpha-4,11-diene, artemisinic
acid, dihydroartemisinic acid, artemisinic alcohol, dihydroartemisinic
alcohol, artemisinic aldehyde and dihydroartemisinic aldehyde [4]
were injected for reference.
Analysis by LC-QTOF-MS/MS
Non-volatile compounds were analysed using a protocol for
untargeted metabolomics of plant tissues [35]. In brief, 500 mg
infiltrated leaf from each treatment was ground in liquid nitrogen
and extracted with 2 ml methanol:formic acid (1000:1, v/v). The
extracts were prepared by brief vortexing and sonication for
15 min. Then the extracts were centrifuged for 5 min at
13,000 rpm and filtered through 0.2 mm inorganic membrane
filters (RC4, Sartorius, Germany). Liquid chromatography,
coupled to quadrupole time-of-flight mass spectrometry (LC–
QTOF-MS) was performed using a Waters Alliance 2795 HPLC
connected to a Waters 2996 PDA detector and subsequently a
QTOF Ultima V4.00.00 mass spectrometer (Waters, MS
technologies, UK) operating in negative ionization mode. The
column used was an analytical column (Luna 3 m C18/2 100A;
2.06150 mm; Phenomenex, USA) attached to a C18 pre-column
(2.064 mm; AJO-4286; Phenomenex, USA). Degassed eluent
A (ultra pure water:formic acid (1000:1,v/v) ) and eluent B
(acetonitril:formic acid (1000:1,v/v) ) were used at 0.19 ml.min21.
The gradient started at 5% B and increased linearly to 35% B
in 45 min, after which the column was washed and equilibrated
for 15 min before the next injection. The injection volume
was 5 ml. The MS-MS measurements were done with collision
energies of 10, 15, 25, 35 and 50 eV. Leucine enkaphalin ([M-
H]2=554.2620) was used as a lock mass for on-line accurate mass
correction.
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Analysis of LC-MS data and identification of AA-di-hexose
LC-MS data were analysed using MassLynx 4.0 (Waters). The data
were first processed using MetAlign version 1.0 (www.metAlign.nl) for
baseline correction, noise elimination and subsequent spectral data
alignment [35]. The processing parameters of MetAlign were set to
analyze from scan number 60 to 2300 with a maximum amplitude of
35000.Mass signals below 10 times the local noise were filtered out and
the resulting data matrix contained intensity values (calculated as peak
heights) for 6645 mass signals aligned across all samples. The mass
intensity data were 2log-transformed. Mass signal intensities obtained
from transgenic plants and empty vector control plants were compared
using the Student’s t-test. Masses with a significant (p,0.05) intensity
change of at least 2-fold were verified manually in the original
chromatograms. Mass-directed LC-MS/MS analysis was done on
differential compounds with signal intensities higher than 500 ion
counts per scan.
Compound isolation by LC-FC/SPE
First purification was carried out on an Agilent 1200 system
(Agilent Technology, SantaClara (CA) USA) equipped with an
analytical scale fraction collector, using Zorbax Eclipse XDB-C18,
5 mm, 4.66150 mm column (Agilent). at an isocratic concentra-
tion of 35% acetonitrile and 0.1% formic acid. In this purification
step the compound of interest is separated from most of the other
compounds in the sample. A second purification was carried out
on the same system, now using a Prospekt 2 and general purpose
(GP) cartridges (SPARK Holland) to trap the compound. The
material was dried for at least 40 minutes under N2 air flow.
Elution was performed using 600 uL of deuterated acetonitrile
(99.96%, Eurisotop).
NMR spectroscopy
NMR analysis was performed at Spinnovations BV (Nijmegen)
on a Bruker Avance III 500 MHz spectrometer equipped with a 5-
mm CPTCI cryo probe (1H-13C/15N/2H + Z-gradients) operating
at 303 K. The structure identification of artemisinic acid as a
reference compound is based on a 1D 1H, 1H-1H-DQF-COSY,
1H-1H-TOCSY, 1H-1H-NOESY, 1H-13C-HSQC and 1H-13C-
HMBC spectra. The structure identification of the purified
compound is based on the same selection of NMR experiments
with the exception of the 1H-13C-HMBC spectrum due to the
limited amount of material. The proton and carbon chemical shifts
were referenced to the internal reference TMS (proton,
d=0.00 ppm; carbon, d=0.00 ppm). The data were processed
using Topspin 2.1 pl5.
Glycosidase treatment
To identify glycosylated metabolites, 0.5 mg of purified AA-
dihexoside was tested in the appropriate buffer system with 0.1
unit of yeast a-glucosidase (Sigma; 50 mM potassium phosphate
pH=7.5), almond b-glucosidase (Sigma; 50 mM sodium acetate
pH=5.6) or jack bean b-galactosidase (50 mM citrate
pH=4+0.01% BSA), and incubated for 3 hrs at 37uC. Samples
were analyzed using LC-MS and GC-MS as described above.
To quantify AA-diglucoside, 200 mg infiltrated leaf material
from each treatment was ground in liquid nitrogen and extracted
with 1 ml citrate phosphate buffer, pH 5.4. The extracts were
prepared by brief vortexing and sonication for 15 min. 200 ml of
ViscozymL (Sigma) was added and the sample again vortexed.
The mixture was incubated overnight at 37uC, and subsequently
extracted three times with 1 ml of ethyl acetate. Extracts were
dehydrated using Na2SO4, concentrated to approximately 250 ml
and methylated using diazomethane. An internal standard, cis-
nerolidol, was used to quantify the products. Artemisinic acid,
when present in a plant extract, was not fully methylated by
diazomethane. Therefore, both unmethylated artemisinic acid
(selective mass m/z 234, Rt = 17.69; Fig. S5) and methylated
artemisinic acid (total ion count, Rt 16.98 min; Fig. S6) standards
were used for quantification. Samples were analyzed using GC-
MS as described above.
Supporting Information
Table S1 Mass signals significantly different between samples
infiltrated with 35S-mAmFH-2A + 35S-CYP71AVI and 35S-
mAmFH-2A. Data are sorted by retention time.
Found at: doi:10.1371/journal.pone.0014222.s001 (1.04MBDOC)
Figure S1 Mass spectrum (negative mode) of artemisinic acid-
12-b-diglucoside, showing a base-peak mass ([M-H]), a formic acid
adduct ([M-H + H2CO2]) and a dimeric mass ([2M-H]).
Found at: doi:10.1371/journal.pone.0014222.s002 (0.01 MB PDF)
Figure S2 MSMS mass spectrum, showing collision mass
fragments of artemisinic acid-12-b-diglucoside (m/z 557.24; [M-
H]).
Found at: doi:10.1371/journal.pone.0014222.s003 (0.01 MB PDF)
Figure S3 The effect of b-glucosidase on artemisinic acid-12-b-
diglucoside. (A) Total ion count mass chromatograms and (B)
chromatograms at m/z = 791.5. Represented are chromatograms
of artemisinic acid-12-b-diglucoside treated with control (thin line)
or b-glucosidase (bold line). The peak at Rt = 28.0 min represents
artemisinic acid-12-b-diglucoside, the peak at Rt = 53.2 min
represents artemisinic acid monoglucoside.
Found at: doi:10.1371/journal.pone.0014222.s004 (0.02 MB PDF)
Figure S4 GC-MS chromatogram (total ion count) of viscozym-
treated extracts of N. benthamiana leaves infiltrated with 35S-
mAmFH-2A (bottom) or with 35S-mAmFH-2A + 35S-CY-
P71AV1 (top). Indicated peaks have been further analyzed.
Found at: doi:10.1371/journal.pone.0014222.s005 (0.01 MB PDF)
Figure S5 GC-MS chromatogram (m/z 234) of viscozym-
treated extracts of N. benthamiana leaves infiltrated with 35S-
mAmFH-2A (bottom), with 35S-mAmFH-2A + 35S-CYP71AV1
(middle), or artemisinic acid standard (top). Mass spectra of
artemisinic acid and the artemisinic acid produced in tobacco are
shown.
Found at: doi:10.1371/journal.pone.0014222.s006 (0.04 MB PDF)
Figure S6 GC-MS chromatogram (m/z 248) of viscozym-
treated extracts of N. benthamiana leaves infiltrated with 35S-
mAmFH-2A (bottom), with 35S-mAmFH-2A + 35S-CYP71AV1
(middle), or artemisinic acid standard (top). Mass spectra of
methylation products of artemisinic acid and the artemisinic acid
produced in tobacco are shown.
Found at: doi:10.1371/journal.pone.0014222.s007 (0.03 MB PDF)
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